New survey identifies opportunity to improve shared decision making between cardiologists and heart valve disease patients

Dublin, may 14, 2021 /prnewswire/ -- new findings from an american college of cardiology's (acc) survey revealed more than half of cardiologists (57%) believe patient preparation may lead to better quality discussions around treatment options for heart valve disease (hvd). results from the acc cardiosurve panelist survey, sponsored by medtronic (nyse: mdt), and conducted by the american college of cardiology, garnered responses from more than 150 cardiologists around key factors driving treatment choices for patients with symptomatic severe aortic stenosis.
MDT Ratings Summary
MDT Quant Ranking